Anthoula Koliadi

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer

Ladjevardi, Cecilia Olsson; Skribek, Marcus; Koliadi, Anthoula; Rydén, Viktoria et al.

Ingår i Cancer Immunology and Immunotherapy, 2025

• DOI för Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
• Ladda ner fulltext (pdf) av Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Sköld, Camilla; Corvigno, Sara; Dahlstrand, Hanna; Enblad, Gunilla et al.

Ingår i Cancer Causes and Control, s. 1101-1109, 2024

• DOI för Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
• Ladda ner fulltext (pdf) av Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Evaluation of a cervical cancer-specific restriction spectrum imaging model on an independent pilot cohort using PET/MRI: pre- and post-therapy

Lundström, Elin; Rodríguez-Soto, Ana E.; Hedlund, Elisabeth; Jónsdóttir, Björg et al.

Ingår i Proceedings of the International Society for Magnetic Resonance in Medicine 32nd Annual Meeting, Singapore, May 04-09, 2024, 2024

• Ladda ner fulltext (pdf) av Evaluation of a cervical cancer-specific restriction spectrum imaging model on an independent pilot cohort using PET/MRI: pre- and post-therapy

Correction of B₀-related distortions in diffusion-weighted images of malignant and normal cervical tissue

Lundström, Elin; Rodríguez-Soto, Ana E.; Conlin, Christopher; Loubrie, Stephane et al.

Ingår i Proceedings of the International Society for Magnetic Resonance in Medicine 32nd Annual Meeting, 2024

• Ladda ner fulltext (pdf) av Correction of B₀-related distortions in diffusion-weighted images of malignant and normal cervical tissue

Early experience of tumor detection and therapy response assessment in cervical cancer using advanced DWI in PET/MRI

Hedlund, Elisabeth; Lundström, Elin; Rodríguez-Soto, Ana E.; Jonsdottir, Björg et al.

Ingår i Abstracts - 30th European Symposium on Urogenital Radiology, 2024

• Ladda ner fulltext (pdf) av Early experience of tumor detection and therapy response assessment in cervical cancer using advanced DWI in PET/MRI

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer

Ladjevardi, Cecilia Olsson; Skribek, Marcus; Koliadi, Anthoula; Rydén, Viktoria et al.

Ingår i Cancer Immunology and Immunotherapy, 2025

• DOI för Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
• Ladda ner fulltext (pdf) av Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Sköld, Camilla; Corvigno, Sara; Dahlstrand, Hanna; Enblad, Gunilla et al.

Ingår i Cancer Causes and Control, s. 1101-1109, 2024

• DOI för Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
• Ladda ner fulltext (pdf) av Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Sköld, Camilla; Corvigno, Sara; Dahlstrand, Hanna; Enblad, Gunilla et al.

Ingår i Cancer Causes and Control, s. 1101-1109, 2024

• DOI för Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
• Ladda ner fulltext (pdf) av Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness

Ladjevardi, Cecilia Olsson; Koliadi, Anthoula; Rydén, Viktoria; El-Naggar, Ali Inan et al.

Ingår i Frontiers in Oncology, 2024

• DOI för Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness
• Ladda ner fulltext (pdf) av Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness

The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis

Rydén, Viktoria; El-Naggar, Ali Inan; Koliadi, Anthoula; Ladjevardi, Cecilia Olsson et al.

Ingår i Pigment Cell & Melanoma Research, 2024

• DOI för The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
• Ladda ner fulltext (pdf) av The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis

Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study

Ladjevardi, Cecilia Olsson; Koliadi, Anthoula; Rydén, Viktoria; Inan El-Naggar, Ali et al.

Ingår i Cancer Medicine, s. 13217-13224, 2023

• DOI för Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
• Ladda ner fulltext (pdf) av Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study

Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Sköld, Camilla; Koliadi, Anthoula; Enblad, Gunilla; Stålberg, Karin et al.

Ingår i International Journal of Cancer, s. 773-781, 2022

• DOI för Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
• Ladda ner fulltext (pdf) av Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

Valachis, Antonios; Rosén, Camilla; Koliadi, Anthoula; Digkas, Evangelos et al.

Ingår i Oncoimmunology, 2021

• DOI för Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors
• Ladda ner fulltext (pdf) av Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

Tholander, Bengt; Koliadi, Anthoula; Botling, Johan; Dahlstrand, Hanna et al.

Ingår i Upsala Journal of Medical Sciences, s. 325-329, 2020

• DOI för Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

High proliferation is associated with inferior outcome in male breast cancer patients

Nilsson, Cecilia; Koliadi, Anthoula; Johansson, Ida; Ahlin, Cecilia et al.

Ingår i Modern Pathology, s. 87-94, 2013

• DOI för High proliferation is associated with inferior outcome in male breast cancer patients

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort

Niméus-Malmström, Emma; Koliadi, Anthoula; Ahlin, Cecilia; Holmqvist, Marit et al.

Ingår i International Journal of Cancer, s. 961-967, 2010

• DOI för Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

Koliadi, Anthoula; Nilsson, Cecilia; Holmqvist, Marit; Holmberg, Lars et al.

Ingår i Acta Oncologica, s. 816-820, 2010

• DOI för Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

The Prognostic Impact of Proliferation Markers in Breast Cancer with Emphasis on Cyclin B1 and PPH3

Koliadi, Anthoula

2014

• Ladda ner fulltext (pdf) av The Prognostic Impact of Proliferation Markers in Breast Cancer with Emphasis on Cyclin B1 and PPH3

Evaluation of a cervical cancer-specific restriction spectrum imaging model on an independent pilot cohort using PET/MRI: pre- and post-therapy

Lundström, Elin; Rodríguez-Soto, Ana E.; Hedlund, Elisabeth; Jónsdóttir, Björg et al.

Ingår i Proceedings of the International Society for Magnetic Resonance in Medicine 32nd Annual Meeting, Singapore, May 04-09, 2024, 2024

• Ladda ner fulltext (pdf) av Evaluation of a cervical cancer-specific restriction spectrum imaging model on an independent pilot cohort using PET/MRI: pre- and post-therapy

Correction of B₀-related distortions in diffusion-weighted images of malignant and normal cervical tissue

Lundström, Elin; Rodríguez-Soto, Ana E.; Conlin, Christopher; Loubrie, Stephane et al.

Ingår i Proceedings of the International Society for Magnetic Resonance in Medicine 32nd Annual Meeting, 2024

• Ladda ner fulltext (pdf) av Correction of B₀-related distortions in diffusion-weighted images of malignant and normal cervical tissue

Early experience of tumor detection and therapy response assessment in cervical cancer using advanced DWI in PET/MRI

Hedlund, Elisabeth; Lundström, Elin; Rodríguez-Soto, Ana E.; Jonsdottir, Björg et al.

Ingår i Abstracts - 30th European Symposium on Urogenital Radiology, 2024

• Ladda ner fulltext (pdf) av Early experience of tumor detection and therapy response assessment in cervical cancer using advanced DWI in PET/MRI

Association between parity, histopathological tumor features and survival in high-grade serous ovarian cancer

Sköld, Camilla; Tolf, Anna; Corvigno, Sara; Dahlstrand, Hanna et al.